Howard Burris III
Sarah Cannon

Last Updated On 8/17/2020 9:42:32 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Leadership
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Stock and Other Ownership Interests
Company: HCA Healthcare / Sarah Cannon
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: AstraZeneca
Recipient: Your Institution
Company: FORMA Therapeutics
Recipient: Your Institution
Company: Celgene
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Roche/Genentech
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: AstraZeneca
Recipient: Your Institution
Company: MedImmune
Recipient: Your Institution
Company: Macrogenics
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: Boehringer Ingelheim
Recipient: Your Institution
Company: Lilly
Recipient: Your Institution
Company: Seattle Genetics
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Agios
Recipient: Your Institution
Company: Jounce Therapeutics
Recipient: Your Institution
Company: Moderna Therapeutics
Recipient: Your Institution
Company: CytomX Therapeutics
Recipient: Your Institution
Company: GlaxoSmithKline
Recipient: Your Institution
Company: Verastem
Recipient: Your Institution
Company: Tesaro
Recipient: Your Institution
Company: BioMed Valley Discoveries
Recipient: Your Institution
Company: TG Therapeutics
Recipient: Your Institution
Company: Vertex
Recipient: Your Institution
Company: eFFECTOR Therapeutics
Recipient: Your Institution
Company: Janssen
Recipient: Your Institution
Company: Gilead Sciences
Recipient: Your Institution
Company: BioAtla
Recipient: Your Institution
Company: CicloMed
Recipient: Your Institution
Company: Harpoon therapeutics
Recipient: Your Institution
Company: Arch
Recipient: Your Institution
Company: Arvinas
Recipient: Your Institution
Company: Revolution Medicines
Recipient: Your Institution
Company: Array BioPharma
Recipient: Your Institution
Company: Bayer
Recipient: Your Institution
Company: BIND Therapeutics
Recipient: Your Institution
Company: Kymab
Recipient: Your Institution
Company: miRNA Therapeutics
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution
Company: Takeda/Millennium
Recipient: Your Institution
Company: Foundation Medicine
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
Company: Novartis
Recipient: Your Institution

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
Company: Daiichi Sankyo
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/201030/summary